Stock IP INTER PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Inter Pharma

Equities

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
6.15 THB -2.38% Intraday chart for Inter Pharma -1.60% +11.04%
05-14 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-26 Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 1,308 2,699 5,811 5,513 3,353
Enterprise Value (EV) 1 974.5 2,666 5,993 5,275 3,339
P/E ratio 22.9 x 50.2 x 54.2 x 40.6 x 66 x
Yield 2.91% 0.18% - 1.22% 0.39%
Capitalization / Revenue 3.48 x 6.04 x 6.31 x 3.59 x 1.86 x
EV / Revenue 2.59 x 5.97 x 6.51 x 3.44 x 1.86 x
EV / EBITDA 15.3 x 32.4 x 35 x 25.3 x 19.9 x
EV / FCF -104 x 112 x -18.9 x 134 x -63.8 x
FCF Yield -0.96% 0.89% -5.3% 0.75% -1.57%
Price to Book 2.87 x 5.73 x 7.63 x 2.86 x 1.75 x
Nbr of stocks (in thousands) 468,650 468,650 484,267 605,346 605,346
Reference price 2 2.791 5.758 12.00 9.108 5.538
Announcement Date 24/02/20 25/02/21 25/02/22 28/02/23 01/03/24
1THB in Million2THB
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 314.4 375.9 446.9 921 1,534 1,799
EBITDA 1 42.71 63.62 82.3 171.4 208.7 167.7
EBIT 1 40.96 61.77 78.5 145.8 171.7 109.4
Operating Margin 13.03% 16.43% 17.56% 15.83% 11.19% 6.08%
Earnings before Tax (EBT) 1 40.27 60.95 77.2 137.7 147.6 81.37
Net income 1 29.68 43.47 53.78 105.2 119.2 50.79
Net margin 9.44% 11.57% 12.03% 11.42% 7.77% 2.82%
EPS 2 0.1169 0.1220 0.1147 0.2214 0.2241 0.0839
Free Cash Flow 1 -20.87 -9.36 23.81 -317.6 39.41 -52.37
FCF margin -6.64% -2.49% 5.33% -34.49% 2.57% -2.91%
FCF Conversion (EBITDA) - - 28.93% - 18.88% -
FCF Conversion (Net income) - - 44.27% - 33.05% -
Dividend per Share 2 0.0391 0.0813 0.0103 - 0.1108 0.0214
Announcement Date 22/05/19 24/02/20 25/02/21 25/02/22 28/02/23 01/03/24
1THB in Million2THB
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales - - 441.1 - -
EBITDA - - 70.61 - -
EBIT - - 38.75 - -
Operating Margin - - 8.78% - -
Earnings before Tax (EBT) - - 41.53 - -
Net income 1 36.06 30.45 28.23 40.06 11.34
Net margin - - 6.4% - -
EPS - 0.0554 0.0455 0.0677 -
Dividend per Share - - - - -
Announcement Date 25/02/22 11/11/22 28/02/23 12/05/23 11/08/23
1THB in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 182 - -
Net Cash position 1 20.9 334 32.5 - 238 13.3
Leverage (Debt/EBITDA) - - - 1.059 x - -
Free Cash Flow 1 -20.9 -9.36 23.8 -318 39.4 -52.4
ROE (net income / shareholders' equity) 31.3% 16.5% 12.7% 17.4% 8.96% 2.78%
ROA (Net income/ Total Assets) 17.3% 10.7% 7.69% 8.75% 4.93% 2.26%
Assets 1 172 406.1 699.2 1,203 2,418 2,244
Book Value Per Share 2 0.3400 0.9700 1.010 1.570 3.180 3.160
Cash Flow per Share 2 0.1100 0.7300 0.3300 0.3600 1.280 0.6800
Capex 1 9.22 0.62 12.5 224 27.4 106
Capex / Sales 2.93% 0.17% 2.79% 24.34% 1.78% 5.92%
Announcement Date 22/05/19 24/02/20 25/02/21 25/02/22 28/02/23 01/03/24
1THB in Million2THB
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
6.15
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
INTER PHARMA Stock Inter Pharma
+11.04% 105M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.49% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IP Stock
  4. Financials Inter Pharma